Purple Biotech regains compliance with Nasdaq

Purple Biotech (PPBT) received confirmation from the Listing Qualifications Department of Nasdaq that the company had regained compliance with the minimum bid price requirement for continued listing on Nasdaq, and is now compliant with applicable listing standards for continued Nasdaq listing. The company was required to maintain a minimum closing bid price for the ADSs of $1.00 per share or more for at least 10 consecutive business days, which was achieved on March 13.